EUVIMEDEUVIMED entdecken
Crossref

Active Surveillance for Prostate Cancer in “Real-World” Setting: Exploring Racial Disparities

Alessio Finocchiaro, Giuseppe Chiarelli, Alex Stephens, Silvia Viganó, Alessandro Bertini, Nicholas Cusmano, Elnaz Guivatchian, Arjun Dinesh, Vincenzo Ficarra, Gabriele Sorce, Alberto Briganti, Francesco Montorsi und 6 weitere

Journal of Racial and Ethnic Health Disparities · 2025

DOI: 10.1007/s40615-025-02497-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Racial and Ethnic Health Disparities, 2025. Verfasst von Alessio Finocchiaro und 17 weiteren Autor:innen. Beteiligte Einrichtung: VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA. Hauptthemen laut MEDLINE: Black or African American, Health Status Disparities, Healthcare Disparities, Prostatic Neoplasms. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Active surveillance (AS) is a safe management strategy for low-risk prostate cancer (PCa), but limited "real-world" data exist outside trial cohorts. This study investigates racial disparities in progression to treatment, upgrading, and prostate cancer-specific mortality (PCSM) in a real-world AS population, aiming to improve healthcare quality. METHODS: We retrospectively analyzed data from the Henry Ford Health System (1995-2023) for men diagnosed with PCa (Gleason Grade ≤ 2, ≤ cT2c, N0-M0, PSA ≤ 20 ng/ml, age < 76 years) and enrolled in AS with ≥ 1 post-diagnosis PSA or biopsy and ≥ 1 year follow-up. Non-Hispanic Blacks (NHBs) and Non-Hispanic Whites (NHWs) were included. Surveillance adequacy was defined as ≥ 1 PSA/year and ≥ 1 biopsy every 4 years. Competing-risk cumulative incidence and regression assessed disparities in progression to treatment, upgrading, and PCSM. RESULTS: Among 864 patients (38% NHBs, 62% NHWs), NHBs presented with more advanced disease, including higher rates of GG2 (29% vs. 18%, p < 0.001) and intermediate-risk PCa (39% vs. 32%, p = 0.04). Surveillance adequacy was lower in NHBs (38% vs. 50%, p < 0.001). NHBs progressed to treatment more frequently (45% vs. 36%, p < 0.001), with a 1.46-fold higher risk (95% CI: 1.14-1.87, p = 0.003). NHBs had no higher odds of upgrading but showed higher 10-year PCSM (5.6% vs. 1.4%) and 5.9-fold higher odds of PCSM (95% CI: 1.38-25.37, p = 0.01). CONCLUSIONS: NHBs under AS face more advanced disease, lower follow-up adequacy, higher progression to treatment, and elevated PCSM odds. Targeted strategies are needed to address these disparities and improve equitable PCa care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanHealth Status DisparitiesHealthcare DisparitiesProstatic NeoplasmsWatchful WaitingWhiteAgedHumansMaleMiddle AgedDisease ProgressionProstate-Specific AntigenRetrospective Studies

Stichwörter der Autor:innen

Active surveillanceProstate-specific antigenProstatic neoplasmsRacial disparity

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • VUI Center for Outcomes Research, Analysis, and Evaluation, Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA.
  • Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.
  • Public Health Sciences, Henry Ford Health System, Detroit, MI, USA.
  • Department of Clinical and Experimental Medicine, Urologic section, University of Messina, Messina, Italy.
  • Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
  • School of Medicine, Wayne State University, Detroit, MI, USA.

Zitieren

APA

Finocchiaro, A., Chiarelli, G., Stephens, A., Viganó, S., Bertini, A., Cusmano, N., Guivatchian, E., Dinesh, A., Ficarra, V., Sorce, G., Briganti, A., Montorsi, F., Salonia, A., Lughezzani, G., Buffi, N., Sood, A., Rogers, C., & Abdollah, F. (2025). Active Surveillance for Prostate Cancer in “Real-World” Setting: Exploring Racial Disparities. Journal of Racial and Ethnic Health Disparities. https://doi.org/10.1007/s40615-025-02497-4

Vancouver

Finocchiaro A, Chiarelli G, Stephens A, Viganó S, Bertini A, Cusmano N, et al. Active Surveillance for Prostate Cancer in “Real-World” Setting: Exploring Racial Disparities. Journal of Racial and Ethnic Health Disparities. 2025. doi:10.1007/s40615-025-02497-4

BibTeX
@article{Finocchiaro2025,
  author = {Finocchiaro, Alessio and Chiarelli, Giuseppe and Stephens, Alex and Viganó, Silvia and Bertini, Alessandro and Cusmano, Nicholas and Guivatchian, Elnaz and Dinesh, Arjun and Ficarra, Vincenzo and Sorce, Gabriele and Briganti, Alberto and Montorsi, Francesco and Salonia, Andrea and Lughezzani, Giovanni and Buffi, Nicolò and Sood, Akshay and Rogers, Craig and Abdollah, Firas},
  title = {Active Surveillance for Prostate Cancer in “Real-World” Setting: Exploring Racial Disparities},
  journal = {Journal of Racial and Ethnic Health Disparities},
  year = {2025},
  doi = {10.1007/s40615-025-02497-4}
}
Kostenlos starten →